From: Ilena Rose on
Note from Ilena Rosenthal: Unfortunately, the industry / ACSH /
quackwatch / Barrett & Gots etc. have mislabeled MCS a "fad diagnosis"
and minimized the severity and insulted the victims.

http://www.BreastImplantAwareness.org/QuackWatchWatch.htm


http://thetruthaboutmcs.blogspot.com/2007/08/multiple-chemical-sensitivity-study-of.html
Sunday, August 19, 2007
Multiple chemical sensitivity: study of 52 cases.]

Med Clin (Barc). 2007 Jun 16;129(3):96-9.
[Multiple chemical sensitivity: study of 52 cases.]
[Article in Spanish]

Nogu� S, Fern�ndez-Sol� J, Rovira E, Montori E, Fern�ndez-Huerta JM,
Munn� P.
Unidades de Toxicolog�a y de Fatiga Cr�nica. Hospital Cl�nic. IDIBAPS.
Universidad de Barcelona. Barcelona. Espa�a. SNOGUE(a)clinic.ub.es.

BACKGROUND AND OBJECTIVE: Multiple chemical sensitivity (MCS) is
characterized by a loss of tolerance to various environmental
chemicals. The objective of this study was to describe patients with
MCS seen in our hospital.
PATIENTS AND METHOD: Patients consecutively seen by the Toxicology and
Chronic Fatigue Units who presented symptoms of MCS were included. The
diagnosis was clinical. All patients completed the Quick Environmental
Exposure and Sensitivity Inventory (QEESI) questionnaire.
RESULTS: Fifty-two patients were included. The average age (standard
deviation) was 47.2 (7.6) years, and 46 (88%) were females. The origin
of the syndrome was related to occupational exposure to various
chemical agents in 31 cases (59.6%), including occupational accidents
in 14 patients (fumigation of the workplace with insecticides). In 20
patients (38.5%), the syndrome could not be associated with any toxic
exposure and was considered a manifestation of chronic fatigue
syndrome. The QEESI showed mean scores of 72.9 (18.6) on the chemical
inhalant intolerance scale, 45.5 (20.6) on the other intolerances
scale, 69.8 (20.6) on the symptom severity scale, 4.4 (1.8) on the
masking index and 66.6 (21.7) on the life impact scale. All patients
were followed up for a minimum of 12 months, and during this period
they remained stable with no deaths.
CONCLUSIONS: MCS normally affects middle-aged women. It is frequently
triggered by exposure to chemical agents, especially insecticides. An
association with chronic fatigue syndrome is common. The prognosis is
good but the patients' quality of life is seriously affected.

PMID: 17594860 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17594860&itool=iconabstr&itool=pubmed_DocSum
Posted by MCS America at 11:06 AM
)

From: Peter Moran on

"Ilena Rose" <BIA(a)mundo.com> wrote in message
news:6fphc3dcf2rmmv3a0or9d69slp8qe6kf8j(a)4ax.com...
> Note from Ilena Rosenthal: Unfortunately, the industry / ACSH /
> quackwatch / Barrett & Gots etc. have mislabeled MCS a "fad diagnosis"
> and minimized the severity and insulted the victims.
>
> http://www.BreastImplantAwareness.org/QuackWatchWatch.htm
>
>
> http://thetruthaboutmcs.blogspot.com/2007/08/multiple-chemical-sensitivity-study-of.html
> Sunday, August 19, 2007
> Multiple chemical sensitivity: study of 52 cases.]
>
> Med Clin (Barc). 2007 Jun 16;129(3):96-9.
> [Multiple chemical sensitivity: study of 52 cases.]
> [Article in Spanish]
>
> Nogu� S, Fern�ndez-Sol� J, Rovira E, Montori E, Fern�ndez-Huerta JM,
> Munn� P.
> Unidades de Toxicolog�a y de Fatiga Cr�nica. Hospital Cl�nic. IDIBAPS.
> Universidad de Barcelona. Barcelona. Espa�a. SNOGUE(a)clinic.ub.es.
>
> BACKGROUND AND OBJECTIVE: Multiple chemical sensitivity (MCS) is
> characterized by a loss of tolerance to various environmental
> chemicals. The objective of this study was to describe patients with
> MCS seen in our hospital.
> PATIENTS AND METHOD: Patients consecutively seen by the Toxicology and
> Chronic Fatigue Units who presented symptoms of MCS were included. The
> diagnosis was clinical. All patients completed the Quick Environmental
> Exposure and Sensitivity Inventory (QEESI) questionnaire.
> RESULTS: Fifty-two patients were included. The average age (standard
> deviation) was 47.2 (7.6) years, and 46 (88%) were females. The origin
> of the syndrome was related to occupational exposure to various
> chemical agents in 31 cases (59.6%), including occupational accidents
> in 14 patients (fumigation of the workplace with insecticides). In 20
> patients (38.5%), the syndrome could not be associated with any toxic
> exposure and was considered a manifestation of chronic fatigue
> syndrome. The QEESI showed mean scores of 72.9 (18.6) on the chemical
> inhalant intolerance scale, 45.5 (20.6) on the other intolerances
> scale, 69.8 (20.6) on the symptom severity scale, 4.4 (1.8) on the
> masking index and 66.6 (21.7) on the life impact scale. All patients
> were followed up for a minimum of 12 months, and during this period
> they remained stable with no deaths.
> CONCLUSIONS: MCS normally affects middle-aged women. It is frequently
> triggered by exposure to chemical agents, especially insecticides. An
> association with chronic fatigue syndrome is common. The prognosis is
> good but the patients' quality of life is seriously affected.


Interesting that NONE got better, not one. This shows how patients remain
seriously disabled when encouraged in the pseudodiagnosis of MCS, a
"diagnosis" that reinforces abnormal illness behavior and one which offers
no prospect of a normal life. Many DO get better when shown that their
responses to chemical exposures are mostly psychologically mediated and
that a return to a more normal existence is possible.

Peter Moran
>

From: Medusa on
On Aug 19, 7:56 pm, Ilena Rose <B...(a)mundo.com> wrote:
> Note from Ilena Rosenthal: Unfortunately, the industry / ACSH /
> quackwatch / Barrett & Gots etc. have mislabeled MCS a "fad diagnosis"
> and minimized the severity and insulted the victims.

Thanks for posting this, Ilena. Barrett has been lnown to testify
against MCS cases. He is a real chemical indusry shill.

Medusa